279 related articles for article (PubMed ID: 33393127)
1. High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension.
Alam S; Kandasamy D; Goyal A; Vishnubhatla S; Singh S; Karthikeyan G; Khadgawat R
Clin Endocrinol (Oxf); 2021 Jun; 94(6):895-903. PubMed ID: 33393127
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
[TBL] [Abstract][Full Text] [Related]
3. Primary aldosteronism in a general population sample. The Czech post-MONICA study.
Widimský J; Bruthans J; Wohlfahrt P; Krajčoviechová A; Šulc P; Linhart A; Filipovský J; Lánská V; Cífkova R
Blood Press; 2020 Jun; 29(3):191-198. PubMed ID: 32036692
[No Abstract] [Full Text] [Related]
4. Prevalence of primary aldosteronism in primary care: a cross-sectional study.
Käyser SC; Deinum J; de Grauw WJ; Schalk BW; Bor HJ; Lenders JW; Schermer TR; Biermans MC
Br J Gen Pract; 2018 Feb; 68(667):e114-e122. PubMed ID: 29335324
[TBL] [Abstract][Full Text] [Related]
5. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
[TBL] [Abstract][Full Text] [Related]
6. PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION.
Galati SJ; Cheesman KC; Springer-Miller R; Hopkins SM; Krakoff L; Bagiella E; Zhuk RA; Ying TK; Amer C; Boyajian MK; Inabnet WB; Levine AC
Endocr Pract; 2016 Nov; 22(11):1296-1302. PubMed ID: 27893293
[TBL] [Abstract][Full Text] [Related]
7. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM
Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism.
Ng E; Gwini SM; Libianto R; Choy KW; Lu ZX; Shen J; Doery JCG; Fuller PJ; Yang J
J Clin Endocrinol Metab; 2022 Dec; 108(1):33-41. PubMed ID: 36179243
[TBL] [Abstract][Full Text] [Related]
9. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
[TBL] [Abstract][Full Text] [Related]
10. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
Hu Y; Zhang J; Liu W; Su X
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32163576
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of primary aldosteronism in type 2 diabetes mellitus and hypertension: A prospective study from Western India.
Memon SS; Lila A; Barnabas R; Goroshi M; Sarathi V; Shivane V; Patil V; Shah N; Bandgar T
Clin Endocrinol (Oxf); 2022 Apr; 96(4):539-548. PubMed ID: 34580897
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma.
Chen S; Liu H; Luo P; Yu Y
Endocr J; 2021 Mar; 68(3):299-306. PubMed ID: 33100281
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
Tezuka Y; Turcu AF
Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of primary aldosteronism among patients with type 2 diabetes.
Tancredi M; Johannsson G; Eliasson B; Eggertsen R; Lindblad U; Dahlqvist S; Imberg H; Lind M
Clin Endocrinol (Oxf); 2017 Sep; 87(3):233-241. PubMed ID: 28493291
[TBL] [Abstract][Full Text] [Related]
16. Significance of Discordant Results Between Confirmatory Tests in Diagnosis of Primary Aldosteronism.
Fukumoto T; Umakoshi H; Ogata M; Yokomoto-Umakoshi M; Matsuda Y; Motoya M; Nagata H; Nakano Y; Iwahashi N; Kaneko H; Wada N; Miyazawa T; Sakamoto R; Ogawa Y
J Clin Endocrinol Metab; 2021 Jan; 106(2):e866-e874. PubMed ID: 33165595
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of primary hyperaldosteronism.
Araujo-Castro M; Parra-Ramírez P
Med Clin (Barc); 2022 May; 158(9):424-430. PubMed ID: 34924198
[TBL] [Abstract][Full Text] [Related]
18. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
19. What We Know about and What Is New in Primary Aldosteronism.
Ekman N; Grossman AB; Dworakowska D
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255973
[TBL] [Abstract][Full Text] [Related]
20. Primary aldosteronism in diabetic subjects with resistant hypertension.
Umpierrez GE; Cantey P; Smiley D; Palacio A; Temponi D; Luster K; Chapman A
Diabetes Care; 2007 Jul; 30(7):1699-703. PubMed ID: 17429062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
